Balit Corrine R, Horan Rachael, Dorofaeff Tavey, Frndova Helena, Doyle John, Cox Peter N
1Department of Critical Care Medicine, Hospital for Sick Children, Toronto, Ontario, Canada. 2University of Toronto, Toronto, Ontario, Canada. 3Royal Children's Hospital, Brisbane, Queensland, Australia. 4School of Medicine, University of Brisbane, Brisbane, Australia. 5CancerCare Manitoba, Winnipeg, Manitoba, Canada. 6Department of Pediatrics and Child Health, University of Manitoba, Manitoba, Canada.
Pediatr Crit Care Med. 2016 Mar;17(3):e109-16. doi: 10.1097/PCC.0000000000000607.
Mortality for pediatric patients who require intensive care posthematopoietic stem cell transplant still remains high. Previously at our institution, survival rates were 44% for patients who required mechanical ventilation posthematopoietic stem cell transplant. We conducted a review of patients to identify whether there has been any improvement in survival over the past 12 years and to identify any risk factors that contribute to mortality.
Retrospective chart review.
PICU and hematopoietic stem cell transplant unit of a single tertiary children's hospital.
Children less than 18 years old undergoing hematopoietic stem cell transplant who required admission to the ICU between January 2000 and December 2011.
None.
There were 350 separate admissions to the ICU for 206 patients posthematopoietic stem cell transplant. Median Age was 9.3 years (range, 1-17 yr). Median time from hematopoietic stem cell transplant to admission was 35 days (interquartile range, 13-152 d), and 59% of patients were male. Survival to ICU discharge for all admissions was 75%, which equated to 57% of all patients. Of the admissions that required invasive mechanical ventilation, 48% survived to ICU discharge, with a survival to ICU discharge of 36% if there was more than one admission requiring mechanical ventilation. Survival to ICU discharge was 33% if renal replacement therapy was required. Mechanical ventilation, inotrope/vasopressor use, and number of organ dysfunction within an admission were predictors of mortality. Having an underlying malignant condition or an autologous hematopoietic stem cell transplant was associated with a more favorable outcome.
This is the largest single-center series for pediatric patients who require intensive care posthematopoietic stem cell transplant and demonstrates that this group of patients still faces high mortality. There has been an improvement in survival for those patients who require renal replacement therapy and also for patients who require mechanical ventilation more than once; however, the need for mechanical ventilation still remains a significant predictor of mortality.
造血干细胞移植后需要重症监护的儿科患者死亡率仍然很高。此前在我们机构,造血干细胞移植后需要机械通气的患者生存率为44%。我们对患者进行了回顾,以确定过去12年生存率是否有任何改善,并确定导致死亡的任何风险因素。
回顾性病历审查。
一家三级儿童医院的儿科重症监护病房和造血干细胞移植科。
2000年1月至2011年12月期间接受造血干细胞移植且需要入住重症监护病房的18岁以下儿童。
无。
206例造血干细胞移植后的患者共350次入住重症监护病房。中位年龄为9.3岁(范围1 - 17岁)。从造血干细胞移植到入住重症监护病房的中位时间为35天(四分位间距13 - 152天),59%的患者为男性。所有入住患者中,重症监护病房出院生存率为75%,相当于所有患者的57%。需要有创机械通气的入住患者中,48%存活至重症监护病房出院;如果有多次入住需要机械通气,重症监护病房出院生存率为36%。如果需要肾脏替代治疗,重症监护病房出院生存率为33%。机械通气、使用血管活性药物以及一次入住期间器官功能障碍的数量是死亡率的预测因素。患有潜在恶性疾病或进行自体造血干细胞移植与更有利的结果相关。
这是关于造血干细胞移植后需要重症监护的儿科患者的最大单中心系列研究,表明这组患者仍然面临高死亡率。对于需要肾脏替代治疗的患者以及需要多次机械通气的患者,生存率有所提高;然而,需要机械通气仍然是死亡率的一个重要预测因素。